A randomized controlled phase II clinical trial of modulation of intermediate endpoint biomarkers - workstatement no. 61

Ended Definitive Contract Awarded Last action

Contract number
00261199909D261995130
Awardee
Awarding agency
Obligated
$922,000

Award facts

Contract value 33% obligated
$2,765,970.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers
Pricing
Cost No Fee
Place of performance
Baltimore, MD 21231, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 10 $0
Supplemental Agreement for work within scope 9 $0
Other Administrative Action 8 $0
Other Administrative Action 7 $0
Supplemental Agreement for work within scope 6 $0
Supplemental Agreement for work within scope 4 $175,000
Supplemental Agreement for work within scope 3 $326,000
Supplemental Agreement for work within scope 1 $100,000
Original award $321,000

About this award

This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency of the Department of Health and Human Services (HHS), to the University of Wisconsin Hospitals and Clinics Authority (UWHCA) on September 15, 1999. The contract, valued at $2,765,970.00, is for a randomized controlled Phase II clinical trial to study the modulation of intermediate endpoint biomarkers, as described in Workstatement No. 61. The contract does not have a set-aside designation and is scheduled for completion on October 31, 2007. UWHCA, a non-profit hospital and academic medical institution, has an extensive history of serving as a prime contractor and subcontractor for various federal agencies, including the Department of Veterans Affairs (VA), to provide medical services, testing, research, and healthcare support.

Quick answers

Who was awarded contract 00261199909D261995130?

00261199909D261995130 was awarded to University Of Wisconsin Hospitals And Clinics Authority by National Cancer Institute (National Institutes of Health) on September 15, 1999.

How much is contract 00261199909D261995130 worth?

The government has obligated $922,000 on 00261199909D261995130. Its current value, with exercised options, is $2,765,970.

Was contract 00261199909D261995130 competed?

The extent of competition for 00261199909D261995130 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award